Latest Neurotransmitters Stories

April Flowers for redOrbit.com - Your Universe Online Oxytocin is a powerful hormone that plays a huge role in pair bonding. It is stimulated in numerous ways, including sex, birth, and breastfeeding. The ability of oxytocin to facilitate social bonding for human females in both marital and parenting relationships has been documented in a large body of previous research. A new study from Bar-Ilan University reveals that oxytocin administrated to fathers increases their parental...

In a world-first, researchers from the Australian Centre for Nanomedicine at the University of New South Wales (UNSW) in Sydney have developed a nanoparticle that could improve the effectiveness of chemotherapy for neuroblastoma by a factor of five. Neuroblastoma is an aggressive childhood cancer that often leaves survivors with lingering health problems due to the high doses of chemotherapy drugs required for treatment. Anything that can potentially reduce these doses is considered an...

Johns Hopkins team first identified biochemical clue to therapy in brain scans of people with MS Johns Hopkins researchers report the successful use of a form of MRI to identify what appears to be a key biochemical marker for cognitive impairment in the brains of people with multiple sclerosis (MS). In follow-up experiments on mice with a rodent form of MS, researchers were able to use an experimental compound to manipulate that same marker and dramatically improve learning and memory....

Lawrence LeBlond for redOrbit.com - Your Universe Online It’s only natural that married men continue to check out other attractive women that happen to come into their field of view. Occasionally, some of these men also have a tendency to seek out these women and make contact. And some may even pursue these women further. But now, a new study published in Tuesday’s issue of the Journal of Neuroscience has uncovered a surprising new property of a hormone they say will keep married...

WALTHAM, Mass., Nov. 13 , 2012 /PRNewswire/ -- GeNO LLC (www.genollc.com) today announced that its New Drug Application (NDA) for GeNOsyl(TM) MVG-2000 Nitric Oxide Delivery System for neonates with hypoxic respiratory failure, which was filed on August 31, 2012, has been accepted for filing by the U.S. Food and Drug Administration (FDA). "We are pleased with the FDA's acceptance of our NDA submission for review as it is a significant achievement in the regulatory approval process,"...

Scientists may have discovered why the standard treatment for Parkinson's disease is often effective for only a limited period of time. Their research could lead to a better understanding of many brain disorders, from drug addiction to depression, that share certain signaling molecules involved in modulating brain activity. A team led by Bernardo Sabatini, Takeda Professor of Neurobiology at Harvard Medical School, used mouse models to study dopamine neurons in the striatum, a region of...

LAS VEGAS, Oct. 16, 2012 /PRNewswire/ -- Ceretec, Inc. today announced that it has introduced an FDA-listed nitric oxide gas product (NO-Diff(TM) Nitric Oxide 800 ppm Lung Diffusion Mixture) for use in membrane diffusing capacity (DLNO) testing in pulmonary function laboratories in the U.S. Ceretec's NO-Diff(TM) is a gas product classified by the FDA as a Class 1 medical device; however, it will be produced for Ceretec by its medical gas partner in a pharmaceutical GMP facility. Alex...

Researchers have discovered that a form of oxytocin—the hormone responsible for making humans fall in love—has a similar effect on fish, suggesting it is a key regulator of social behavior that has evolved and endured since ancient times. The findings, published in the latest edition of the journal Animal Behaviour, help answer an important evolutionary question: why do some species develop complex social behaviors while others spend much of their lives alone? "We know how this...

WALTHAM, Mass., Aug. 21, 2012 /PRNewswire/ -- GeNO LLC (www.genollc.com), a privately held pharmaceutical company developing a line of inhaled nitric oxide drug products, today announced it has been awarded four (4) additional US patents on its proprietary nitric oxide (NO) generation chemistry and delivery technology. This brings to sixteen (16) the number of US patents that have been awarded to GeNO, with additional patents pending. US patent number 8,211,368, which expires in...

Connecting the dots between two molecules whose levels are decreased in depression and increased by current antidepressants could yield new therapies, researchers say. Serotonin is a neurotransmitter that enables brain cells to communicate and brain-derived neurotropic factor, or BDNF, is a brain-nourishing molecule that also aids connectivity. Popular antidepressants such as Prozac, developed to increase levels of serotonin, have recently been found to also increase BDNF levels, said Dr....